Recruiting NA Endometriosis

New treatment option for Endometriosis

Official title Study on the Self-Administered Use of a Specialized Kit for the Management of Sexual Pain Associated With Endometriosis

ClinicalTrials.gov ID: NCT07683468

What this study is testing

What it's testing
Endometriosis is a complex gynecological condition that affects approximately 10% of women of reproductive age, according to 2023 data from the World Health Organization. Endometriosis is often associated with debilitating pain, particularly during sexual intercourse (dyspareunia).

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 45, women only

You may be able to join if

  • Women aged 18 to 45
  • Sexually active within the past 3 months
  • Confirmed diagnosis of endometriosis
  • Pain during sexual intercourse, as reported by the patient
  • Patients enrolled in or covered by the French social security system.

You likely can't join if

  • Patients participating in another treatment clinical trial for endometriosis.
  • Pregnant, breastfeeding, or laboring women
  • Patients who do not speak French or are unable to provide informed consent for the study
  • Patients with an allergy to any component of the study kit
  • Individuals who do not have a touchscreen mobile phone compatible with the Endo Doute app.
  • Participants whose physical and/or psychological health is severely impaired, which, in the investigator's opinion, may affect the participant's...
See the full eligibility criteria
Who can join
  • Women aged 18 to 45
  • Sexually active within the past 3 months
  • Confirmed diagnosis of endometriosis
  • Pain during sexual intercourse, as reported by the patient
  • Patients enrolled in or covered by the French social security system.
  • Patients who have been informed and have provided their free, informed, and written consent (no later than the day of enrollment and prior to any examination required for the study).
What rules you out
  • Patients participating in another treatment clinical trial for endometriosis.
  • Pregnant, breastfeeding, or laboring women
  • Patients who do not speak French or are unable to provide informed consent for the study
  • Patients with an allergy to any component of the study kit
  • Individuals who do not have a touchscreen mobile phone compatible with the Endo Doute app.
  • Participants whose physical and/or psychological health is severely impaired, which, in the investigator's opinion, may affect the participant's compliance with the study.
  • Participants currently in the exclusion period of another ongoing study at the time of enrollment.
  • Protected participants: adults under guardianship, conservatorship, or other legal protection; or individuals deprived of their liberty by judicial or administrative order.

The study team makes the final eligibility decision.

Where it's taking place

  • Stains, France

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Stains, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.